The Aldridge Mandate
The travel from A quiet, rain-slicked public coffee shop in the city’s central transit hub. to Iris’s minimalist office desk within the Aldridge Tower’s data processing floor. consumed the next hour. Headlights cut cold through the gathering dusk.
The Aldridge Tower lobby hummed with the sterile efficiency of corporate power. Iris Reyes kept her eyes fixed on the elevator doors as they slid open, her badge already in hand, her stride calibrated to the exact pace of someone who belonged here. She’d learned that rhythm over six years—not fast enough to suggest anxiety, not slow enough to invite conversation.
The data processing floor occupied the seventeenth level. Open plan, but not the collaborative kind. Each workstation sat in its own acoustic shadow, the partitions high enough to obscure faces, low enough for management to see across the room. Iris took her seat at desk 17-C, a minimalist configuration of monitors, a keyboard, and a framed photo of Oliver that she kept angled away from the ceiling cameras.
She logged in. The system greeted her with the usual cascade of compliance reminders and data classification warnings. Her credentials granted access to tier-three genomic records—the raw sequencing data that the Aldridge Corporation had spent the last decade acquiring from hospitals, research institutes, and the occasional off-the-books acquisition.
Oliver’s sequence wasn’t in the main database. She’d made sure of that.
The morning passed in the rhythm of keystrokes and coffee refills. She flagged anomalous methylation patterns in a batch of pediatric samples from a clinic in Nebraska. She cross-referenced patient IDs against a registry of known autoimmune conditions. The work was meticulous, rote, and vital—the kind of labor that kept the Aldridge machine running while the executives took credit for the discoveries.
At 11:47 AM, her desk phone rang.
Internal line. Floor supervisor.
“Reyes,” she answered.
“Mr. Aldridge wants to see you. Conference room 4B. Now.”
Not the heir’s office. Not the patriarch’s penthouse. A conference room on the twenty-first floor, neutral ground in the corporate hierarchy. Iris saved her work, locked her terminal, and walked to the elevator with the same measured stride she’d used entering the building.
Conference room 4B had floor-to-ceiling windows overlooking the financial district. The sky had cleared, leaving a hard winter light that made the glass gleam. Jasper Aldridge stood at the head of the table, hands in his pockets, his posture loose in the way of someone who owned every square foot of the building around him.
He was thirty-four, seven years her senior, and he’d inherited his father’s bone structure without the weight of the old man’s cruelty. Jasper’s cruelty was lighter, more precise—a scalpel where Dorian used a hammer.
“Mrs. Reyes,” he said, as if they were old acquaintances. “Thank you for coming up.”
She didn’t sit. “My shift ends at six.”
“I know. I checked your schedule.” Jasper gestured to a tablet on the table. “I also checked your personnel file. Six years of exemplary work. No complaints. No errors. You’ve declined three promotions, all of which would have moved you off the processing floor.”
Iris said nothing.
“That’s unusual,” he continued. “Most people in your position want to climb. Better pay, better visibility, better retirement. But you’ve stayed exactly where you are. Buried in the data. Far from the spotlight.”
She felt the trap closing before she saw its shape.
“I like the work,” she said.
“I’m sure you do.” Jasper picked up the tablet, swiped the screen, and turned it toward her. “But I think you like the access more.”
The display showed a log entry. Date-stamped fifteen months ago. A query on the pediatric genome database, run from her terminal at 2:14 AM. The search parameters were narrow—specific methylation markers, rare sequence variations in the FOXP2 and SHANK3 regions.
Oliver’s markers.
“That was part of a research study,” Iris said. “I was cross-referencing—”
“Don’t.” Jasper’s voice carried no anger, only a kind of tired precision. “I’ve read your research study. It doesn’t exist. You fabricated the authorization code, ran the query, and exported the results to a personal drive. You then deleted the system log entry, but you didn’t know about the backup server in Basel.”
The room felt colder. The winter light seemed to sharpen, cutting through the glass with surgical clarity.
“I also know,” Jasper said, setting the tablet down, “that your son was born with a rare genetic sequence. A sequence that doesn’t appear in any of our databases, which means you never submitted his samples to the mandatory screening program. That’s a violation of your employment contract. Technically, it’s fraud.”
Iris kept her breathing steady. “What do you want?”
“Good. Direct.” Jasper pulled out a chair and sat, lacing his fingers across the table. “I’m offering you a deal. You give us your son’s complete genomic sequence—voluntarily, with signed consent—and we look the other way on the data breach. You stay employed. You get a promotion to tier-five access, a thirty percent salary increase, and full medical coverage for your family. Including Oliver.”
The offer hung in the air, reasonable and generous on its surface. A lifeline thrown to a drowning woman.
Iris had seen enough of the Aldridge corporation to know that lifelines came with hooks.
“Why now?” she asked. “You’ve had this information for fifteen months. Why not confront me then?”
Jasper’s smile was thin, professional. “Because we didn’t understand what we were looking at. But we’ve been running parallel analyses. Your son’s sequence contains a set of regulatory markers that appear to confer exceptional neuroplasticity. Enhanced memory retention. Accelerated pattern recognition. The markers are rare—we’ve found them in fewer than a hundred recorded cases worldwide, and never in the specific configuration that Oliver carries.”
“My son is eight years old. He builds LEGO sets and reads comic books. He’s not a research asset.”
“He is to us.” Jasper’s eyes didn’t waver. “We’re not asking for anything invasive. A blood draw. A cheek swab. We’ll run our analysis and return all results to your family physician. Your son never has to leave your sight.”
“And then what? You patent his markers. You develop a treatment protocol. You sell it for millions while Oliver becomes a case study in your publications.”
“That’s a cynical view of medical research.”
“That’s an accurate view of your family’s business model.”
Jasper leaned back, studying her with an expression that hovered between curiosity and impatience. “This is a generous offer, Mrs. Reyes. The alternative is termination for cause, referral to the licensing board, and a data theft investigation that would likely attract federal attention. You’d lose your job. You’d lose your security clearance. And given the current state of your finances—”
He paused, letting the implication settle.
Iris felt the weight of it. The mortgage on the apartment. The outstanding balance on Oliver’s therapy sessions. The second job she’d taken editing medical transcripts at night, the one she’d never mentioned to anyone in HR.
“I need to think about it.”
“You have until end of business tomorrow.”
“That’s not enough time.”
“It’s all the time I’m willing to give.” Jasper stood, smoothing his tie. “Take the afternoon if you need it. I’ll have HR prepare the paperwork either way.”
He left the room without looking back.
Iris stood at the window for a long moment, watching the traffic crawl through the intersections below. Seventeen stories up. High enough to fall, not high enough to disappear.
She took the stairs back to the processing floor, her footsteps echoing in the concrete stairwell. When she reached her desk, she opened her drawer, retrieved her phone, and checked for messages.
One from Miriam: *Oliver had a good day. Math test went well. Dinner at 7?*
One from Adrian, sent forty minutes ago: *Call me when you can. Something came up.*
She called him from the stairwell, her voice low.
“They know,” she said. “Jasper Aldridge confronted me. They want Oliver’s sequence.”
Silence on the line. Then Adrian’s voice, clipped and controlled: “Are you safe?”
“I’m at work. I’m fine. But they’re giving me until tomorrow to decide.”
“Don’t sign anything. Don’t agree to anything. I’m coming.”
“Adrian—”
“I’m coming. Stay in public areas. Don’t go home alone.”
The line went dead.
Iris returned to her terminal and worked through the afternoon with mechanical precision. She flagged three more anomalies. She filed two compliance reports. She answered emails from colleagues who had no idea that her world was collapsing around her.
At 5:47 PM, the elevator doors opened and Adrian Blackwood stepped onto the processing floor.
He moved with the controlled urgency of a man who had spent his career in high-pressure environments—hospital trauma wings, research labs with million-dollar equipment, boardrooms where the stakes were measured in human lives. His clothes were still damp from the rain, his hair disheveled, his eyes scanning the space with a tactical awareness that made the security guards shift uncomfortably.
Iris saw him before he saw her. She stood, and he crossed the floor in twelve long strides, stopping just short of her desk.
“What else did he say?” Adrian asked, his voice low.
“The offer. The threat. He knows about the data audit I ran.” She kept her hands still, pressed flat against her keyboard tray. “He said Oliver’s markers are rare. Neuroplasticity markers. They want to study them.”
Adrian’s jaw moved, a muscle tensing and releasing. “They want to weaponize them. You know that.”
“I know. But Jasper framed it as medical research. Generous offer. Promotion. Full coverage.”
“Generous offers from the Aldridges come with chains.” Adrian glanced around the floor, his gaze settling on the ceiling cameras. “We need to leave. Now.”
“My shift ends in thirteen minutes.”
“Forget your shift. Grab your bag.”
She did. The security guards watched them cross the lobby, their hands hovering near their radios but not raising them. Adrian didn’t speak again until they were in the elevator, descending toward the ground floor.
“I got a text,” he said. “An hour ago. Unknown number. It said I have seventy-two hours to deliver Oliver, or the protocol activates. That they can make it look like an accident.”
Iris felt the blood drain from her face. “That’s a threat.”
“It’s a deadline.” Adrian watched the floor numbers tick down. “Which means they’re running out of patience. Which means we need to move faster than they expect.”
The elevator doors opened onto the lobby. White marble, chrome fixtures, the Aldridge family crest embedded in the floor. Jasper Aldridge stood near the reception desk, a phone pressed to his ear, his eyes tracking their approach.
He disconnected the call as they passed.
“Dr. Blackwood,” Jasper said, his tone conversational. “I trust Mrs. Reyes filled you in on our proposal.”
Adrian didn’t slow. “Your proposal is extortion.”
“I prefer the term ‘incentivized partnership.’” Jasper fell into step beside them, his shoes clicking against the marble. “The science we’re developing could change everything. Neuroregeneration. Cognitive enhancement. Treatments for conditions that affect millions of people. Your son could be the key to making that happen.”
“My son is a child. Not a key.”
“Children grow up. And the markers he carries—” Jasper stopped walking. “You know what they are, Dr. Blackwood. You recognized them the moment you saw his sequencing report. That’s why you kept it hidden. That’s why you’ve been running your own research, off the grid, without institutional oversight.”
Adrian turned.
The lobby went quiet. The receptionist stopped typing. The security guards shifted their weight, ready to intervene.
“You’ve been watching me,” Adrian said.
“We’ve been monitoring a lot of people. You’re not special in that regard.” Jasper smiled, thin and practiced. “But your son is. And I think you know that the ethical path here is cooperation. The Aldridge Foundation has resources you can’t match. We can protect him. We can study him safely, in controlled conditions, with full medical oversight.”
“You can turn him into a product.”
“I can turn his biology into a therapy.” Jasper’s eyes hardened. “There are children dying, Dr. Blackwood. Children with neurodegenerative diseases that your son’s markers could help cure. If you bury this, if you run, you’re condemning them to death.”
The accusation landed clean, designed to puncture.
Adrian held the gaze. “I’ll take that risk.”
He turned and walked toward the exit, Iris beside him. They were twenty feet from the doors when Jasper’s voice cut through the lobby.
“See you soon, Dr. Blackwood. The boy’s blood is the future.”